On June 20th, Gelonhui reported that Hainan Shuangcheng Pharmaceuticals (002693.SZ) announced that its controlling subsidiary, Ningbo Shuangcheng Pharmaceuticals Co., Ltd. (Ningbo Shuangcheng), recently obtained a "Drug Production Permit" issued by the Zhejiang Provincial Drug Administration. The matter involved in this change is: agreeing to add Zhejiang Heze Pharmaceutical Technology Co., Ltd. as the new entrusted or entrusted enterprise name for Ningbo Shuangcheng, with a production/registration address at Room 201, Building 4, No. 101, 1st Street, Xiasa Street, Qiantang District, Hangzhou City, Zhejiang Province, and the drug name is KY-XES, with no registration number, for joint registration applications (limited to registration applications only), with the entrusted validity period until November 13, 2027. Other content remains unchanged.
双成药业(002693.SZ)：宁波双成药品生产许可证变更 涉及受托生产信息的增加
Hainan Shuangcheng Pharmaceuticals (002693.SZ): Production license of Ningbo Shuangcheng Pharmaceuticals changed, involving an increase in entrusted production information.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.